MarketPulse
A

$ADPT

6 articles found
3 positive
0 negative
3 neutral
The Motley FoolThe Motley Fool··Cory Renauer

Harvest Investment Exits $5.7M ADPT Position Amid Strong 57% Annual Rally

Harvest Investment Services exits $5.7M position in Adaptive Biotechnologies despite stock's 57.78% annual rally. $ADPT remains strong operationally with growing cancer diagnostics segment.
PLTRADPTbiotechnologystock sale
The Motley FoolThe Motley Fool··Robert Izquierdo

Adaptive Biotech COO Sells $271K in Stock, But Company's Growth Story Remains Intact

Adaptive Biotechnologies COO Julie Rubinstein sold 19,037 shares worth $271,000 under a pre-planned trading arrangement, retaining substantial equity as the biotech firm posts strong 55% revenue growth.
ADPToperating lossesrevenue growth
The Motley FoolThe Motley Fool··Cory Renauer

ADPT Executive's $826K Share Sale Signals Liquidity Play, Not Loss of Confidence

$ADPT's President/COO sold $826K in shares via option exercise while retaining 408K shares. MRD revenue grew 46%; Medicare coverage expansion supports growth outlook.
ADPTexecutive compensationbiotechnology
The Motley FoolThe Motley Fool··Jonathan Ponciano

Adaptive Biotech Insider Sells $554K Stake as Revenue Surges 55%—Here's Why It Matters

Adaptive Biotech insider sold $554K in shares via routine plan; company posted 55% revenue growth and dramatically narrowed losses, signaling operational inflection.
MSFTADPTprofitabilityrevenue growth
The Motley FoolThe Motley Fool··Seena Hassouna

Adaptive Biotech President Sells $1.2M in Stock, But Bullish Stance Remains Intact

Adaptive Biotechnologies' president sold $1.21M in shares via pre-planned transaction, yet retains substantial holdings. Stock up 51% annually as core MRD business surges.
ADPTbiotechnologyinsider sale
The Motley FoolThe Motley Fool··Jonathan Ponciano

Adaptive Biotech COO Sells $2.4M in Stock as Revenue Surges 55% YoY

Adaptive Biotechnologies COO Julie Rubinstein sold 179,703 shares for $2.37M via pre-arranged tax plan as company posts strong 55% revenue growth.
ADPTrevenue growthEBITDA